Riskpilot← Back to searchSign inGet full accessEximius Medicus AB
ABActiveOrg 5590131594Byvägen 43Medical specialists activities · NACE 8622Est. 20151-4 employees
Revenue 2025
SEK 537K
-9% vs 2024
EBITDA margin
15.5%
-36% vs 2024
Equity ratio
36.5%
Financial strength
Net profit 2025
SEK 66K
-44% vs 2024
| Revenue | SEK 537K | -9% |
| EBITDA | SEK 83K | -36% |
| Net profit | SEK 66K | -44% |
| Total assets | SEK 375K | +96% |
| Equity | SEK 137K | +92% |
| Employees | — | — |
Legal name
Eximius Medicus AB
Org number
5590131594
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
7 maj 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarverksamhet, läkaruthyrning samt annan därmed förenlig verksamhet.
Address
Byvägen 43
Email
josef.e.a@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 665 | 1 740 | 300 | 591 | 537 |
| Staff expenses | — | −1 229 | −105 | −80 | −135 |
| EBITDA | −118 | 212 | −138 | 130 | 83 |
| Depreciation & amort. | −6 | −8 | −7 | — | — |
| EBIT | −124 | 204 | −144 | 130 | 83 |
| Net financials | −1 | 2 | 4 | −2 | −0 |
| Profit before tax | −125 | 206 | −140 | 129 | 83 |
| Tax | −0 | −22 | — | −11 | −17 |
| Net profit | −125 | 184 | −140 | 117 | 66 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 440 | 889 | 195 | 191 | 375 |
| Equity | 51 | 94 | −46 | 71 | 137 |
| Long-term debt | 159 | 300 | 150 | −3 | −3 |
| Short-term debt | 230 | 495 | 91 | 124 | 242 |
| Total debt | 389 | 795 | 241 | 121 | 238 |
EBITDA margin
15.5%
This company
15.8%
Market median
+2% vs market
20212025
Equity ratio
36.5%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
48.0%
This company
18.4%
Market median
+161% vs market
20212025
Net profit margin
12.2%
This company
8.1%
Market median
+51% vs market
20212025
Asset turnover
1.43×
This company
1.12×
Market median
+28% vs market
20212025
Debt / equity
1.74×
This company
0.62×
Market median
-181% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eximius Medicus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Josef El-Achkar | Chief Executive Officer | 0 companies |
| Sara Ahmad Hassan | Deputy Board Member | 0 companies |